SCHEMBL2297517

SCHEMBL2297517

O=C(O)N1CCCC1=O.[Cu]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.59
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
THRB P10828 1/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43
ALDH1A1 P00352 2/20 0.41
BRD4 O60885 1/20 0.41
BRD2 P25440 1/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.38
MITF O75030 1/20 0.38
CYP3A4 P08684 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28537358 0.98 LMNA (0.57) LMNAKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL59155 0.98
SCHEMBL1857819 0.95 LMNA (0.59) LMNAKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL3620504 0.95 LMNA (0.59) LMNAKMT2ACYP1A2CYP2D6CYP2C9
Ammonia Solution, Strong SCHEMBL4654664 0.95 LMNA (0.59) LMNAKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL10872417 0.95 LMNA (0.59) LMNAKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL839318 0.95 LMNA (0.59) LMNAKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL10871994 0.95 LMNA (0.59) LMNAKMT2ACYP1A2CYP2D6CYP2C9
SCHEMBL1700875 0.95 LMNA (0.59) LMNAKMT2ACYP1A2CYP2D6CYP2C9
Water SCHEMBL9837119 0.95 LMNA (0.59) LMNAKMT2ACYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250332142-A1 BOTANICAL CALMING COMPOSITION TOPIX PHARMACEUTICALS INC (US) 2025-10-30 US claimed
CN-118931503-A High-stability heat transfer medium and preparation method thereof 海南德海致远投资有限公司 2024-11-12 CN claimed
CN-116897950-A Weeding composition and herbicide suitable for low-temperature environment 浙江新安化工集团股份有限公司 2023-10-20 CN claimed
CN-115998630-B Hair-blacking essence and preparation method thereof 北京普世安生物科技有限公司 2023-06-06 CN claimed
CN-115998630-A Hair-blacking essence and preparation method thereof 北京普世安生物科技有限公司 2023-04-25 CN claimed
CN-115524327-A Color development enhancement method based on copper ion complexing effect 上海家化联合股份有限公司 2022-12-27 CN claimed
CN-115073823-A Ionically crosslinked polysaccharide-based gels and use thereof 上海家化联合股份有限公司 2022-09-20 CN claimed
CN-115068361-A Blue copper peptide double agent and use method and application thereof 中山中研化妆品有限公司 2022-09-20 CN claimed
CN-114762663-A Moisturizing composition and preparation method and application thereof 广州极男化妆品有限公司 2022-07-19 CN claimed
CN-113647411-B Copper nanoparticle/molybdenum disulfide composite material and preparation method and application thereof 江南大学 2022-06-10 CN claimed
CN-113647411-A Copper nanoparticle/molybdenum disulfide composite material and preparation method and application thereof 江南大学 2021-11-16 CN claimed
CN-113559309-A Preparation method of repairable skin gel dressing 长春市罡恒电子有限责任公司 2021-10-29 CN claimed
CN-113257458-B Conductor paste for chip resistor electrode 西安宏星电子浆料科技股份有限公司 2021-10-08 CN claimed
CN-113257458-A Conductor paste for chip resistor electrode 西安宏星电子浆料科技股份有限公司 2021-08-13 CN claimed
US-10391047-B2 Mouthrinse formulations comprising fluoride and a metal salt of pyrrolidone carboxylic acid COLGATE-PALMOLIVE COMPANY (US) 2019-08-27 US claimed
US-20170348216-A1 Mouthrinse Formulations Comprising Fluoride and a Metal Salt of Pyrrolidone Carboxylic Acid GABA INTERNATIONAL HOLDING GMBH (CH) 2017-12-07 US claimed
EP-3223781-A1 MOUTHRINSE FORMULATIONS COMPRISING FLUORIDE AND A METAL SALT OF PYRROLIDONE CARBOXYLIC ACID GABA International Holding GmbH (CH) 2017-10-04 EP claimed
WO-2016096028-A1 MOUTHRINSE FORMULATIONS COMPRISING FLUORIDE AND A METAL SALT OF PYRROLIDONE CARBOXYLIC ACID GABA INTERNATIONAL HOLDING AG (CH) 2016-06-23 WO claimed
EP-0411976-B1 Use of organic copper salts for combatting parasitosis in bees BENECHIM SA (BE) 1994-11-09 EP claimed
CN-121990966-A Preparation method of crystalline copper pyrrolidone carboxylate 辽宁大学 2026-05-08 CN disclosed
CN-121990966-A Preparation method of crystalline copper pyrrolidone carboxylate 辽宁大学 2026-05-08 CN disclosed
EP-4687829-A1 COMPOSITION FOR CARING FOR KERATIN MATERIALS L'OREAL (FR) 2026-02-11 EP disclosed
US-20250340743-A1 Polyetheramine-Based Multifunctional Booster TROY TECH II INC (US) 2025-11-06 US disclosed
US-20250332142-A1 BOTANICAL CALMING COMPOSITION TOPIX PHARMACEUTICALS INC (US) 2025-10-30 US disclosed
US-20250302727-A1 COSMETIC USE OF A COMBINATION OF IMMORTELLE EXTRACTS TO REDUCE THE VISIBILITY OF SKIN PORES LABORATOIRES M&L (FR) 2025-10-02 US disclosed
US-12390445-B2 Botanical calming composition TOPIX PHARMACEUTICALS, INC. (US) 2025-08-19 US disclosed
EP-4535999-A1 POLYETHERAMINE-BASED MULTIFUNCTIONAL BOOSTER COMPOSITIONS Troy Technology II, Inc. (US) 2025-04-16 EP disclosed
CN-119564855-A Method for effectively improving skin color darkness by SERPINA1 inhibitor or antagonist 中国科学院上海营养与健康研究所 2025-03-07 CN disclosed
CN-119101499-A Quantum dot, quantum dot composition, and detection reagent and drug containing quantum dot 杭州美联医学股份有限公司 2024-12-10 CN disclosed
EP-4463133-A1 BOTANICAL CALMING COMPOSITION Topix Pharmaceuticals, Inc. (US) 2024-11-20 EP disclosed
CN-118931503-A High-stability heat transfer medium and preparation method thereof 海南德海致远投资有限公司 2024-11-12 CN disclosed
CN-118871084-A Cosmetic use of a combination of non-apoptotic flower extracts for reducing the visibility of skin pores M&L实验室 2024-10-29 CN disclosed
WO-2024197798-A1 COMPOSITION FOR CARING FOR KERATIN MATERIALS L'OREAL (FR) 2024-10-03 WO disclosed
US-20240269053-A1 COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS L'OREAL (FR) 2024-08-15 US disclosed
CN-118476979-A High-viscosity amino acid surfactant gel system 上海应用技术大学 2024-08-13 CN disclosed
US-20240216242-A1 COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS L'OREAL (FR) 2024-07-04 US disclosed
CN-117959232-B Hair-blacking essence composition and preparation method and application thereof 珠海博御中医药研究有限公司 2024-06-11 CN disclosed
CN-117959232-A Hair-blacking essence composition and preparation method and application thereof 珠海博御中医药研究有限公司 2024-05-03 CN disclosed
EP-4358926-A1 COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS L'OREAL (FR) 2024-05-01 EP disclosed
EP-4346752-A1 COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS L'OREAL (FR) 2024-04-10 EP disclosed
CN-117497636-A Heterojunction photovoltaic silver paste added with liquid conductive material and preparation method thereof 苏州思尔维纳米科技有限公司 2024-02-02 CN disclosed
CN-117500476-A Composition for cleaning and/or removing makeup from keratin materials 莱雅公司 2024-02-02 CN disclosed
CN-117377459-A Composition for cleaning and/or removing makeup from keratin materials 莱雅公司 2024-01-09 CN disclosed
WO-2023239912-A1 POLYETHERAMINE-BASED MULTIFUNCTIONAL BOOSTER COMPOSITIONS TROY TECHNOLOGY II, INC. (US) 2023-12-14 WO disclosed
CN-115068361-B Blue copper peptide double-agent and use method and application thereof 中山中研化妆品有限公司 2023-11-03 CN disclosed
CN-116898901-A External genitalia nursing spray and preparation method thereof 陕西科技大学 2023-10-20 CN disclosed
CN-116897950-A Weeding composition and herbicide suitable for low-temperature environment 浙江新安化工集团股份有限公司 2023-10-20 CN disclosed
WO-2023180126-A1 COSMETIC USE OF A COMBINATION OF IMMORTELLE EXTRACTS TO REDUCE THE VISIBILITY OF SKIN PORES LABORATOIRES M&L (FR) 2023-09-28 WO disclosed
US-20230277498-A1 BOTANICAL CALMING COMPOSITION TOPIX PHARMACEUTICALS, INC. 2023-09-07 US disclosed
CN-114306107-B Functional skin product and preparation method thereof 铂曼(浙江)生物科技有限公司 2023-09-01 CN disclosed
WO-2023137151-A1 BOTANICAL CALMING COMPOSITION TOPIX PHARMACEUTICALS, INC. (US) 2023-07-20 WO disclosed
WO-2023117730-A1 EXPANDED COSMETIC COMPOSITION LABORATOIRES M&L (FR) 2023-06-29 WO disclosed
CN-115998630-B Hair-blacking essence and preparation method thereof 北京普世安生物科技有限公司 2023-06-06 CN disclosed
CN-115998630-B Hair-blacking essence and preparation method thereof 北京普世安生物科技有限公司 2023-06-06 CN disclosed
CN-115998630-A Hair-blacking essence and preparation method thereof 北京普世安生物科技有限公司 2023-04-25 CN disclosed
CN-115998630-A Hair-blacking essence and preparation method thereof 北京普世安生物科技有限公司 2023-04-25 CN disclosed
CN-114306106-B Composition for skin and use thereof 铂曼(浙江)生物科技有限公司 2023-03-31 CN disclosed
WO-2022266943-A1 COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS L'OREAL (FR) 2022-12-29 WO disclosed
CN-115524327-A Color development enhancement method based on copper ion complexing effect 上海家化联合股份有限公司 2022-12-27 CN disclosed
CN-115524327-A Color development enhancement method based on copper ion complexing effect 上海家化联合股份有限公司 2022-12-27 CN disclosed
WO-2022246687-A1 COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS L'OREAL (FR) 2022-12-01 WO disclosed
US-11504312-B2 Mouthrinse formulations COLGATE-PALMOLIVE COMPANY (US) 2022-11-22 US disclosed
CN-115073823-A Ionically crosslinked polysaccharide-based gels and use thereof 上海家化联合股份有限公司 2022-09-20 CN disclosed
CN-115068361-A Blue copper peptide double agent and use method and application thereof 中山中研化妆品有限公司 2022-09-20 CN disclosed
CN-114762663-A Moisturizing composition and preparation method and application thereof 广州极男化妆品有限公司 2022-07-19 CN disclosed
CN-113647411-B Copper nanoparticle/molybdenum disulfide composite material and preparation method and application thereof 江南大学 2022-06-10 CN disclosed
WO-2022073484-A1 SKIN COMPOSITION AND USE THEREOF 铂曼(浙江)生物科技有限公司 2022-04-14 WO disclosed
CN-114306107-A Functional skin product and preparation method thereof 铂曼(浙江)生物科技有限公司 2022-04-12 CN disclosed
CN-114306106-A Composition for skin and use thereof 铂曼(浙江)生物科技有限公司 2022-04-12 CN disclosed
CN-113647411-A Copper nanoparticle/molybdenum disulfide composite material and preparation method and application thereof 江南大学 2021-11-16 CN disclosed
CN-113559309-A Preparation method of repairable skin gel dressing 长春市罡恒电子有限责任公司 2021-10-29 CN disclosed
CN-113257458-B Conductor paste for chip resistor electrode 西安宏星电子浆料科技股份有限公司 2021-10-08 CN disclosed
CN-113332196-A Green tea polyphenol repair gel for deep skin repair and preparation method thereof 美卓(杭州)医疗科技有限公司 2021-09-03 CN disclosed
CN-113257458-A Conductor paste for chip resistor electrode 西安宏星电子浆料科技股份有限公司 2021-08-13 CN disclosed
CN-107249556-B Mouthwash formulation comprising fluoride and metal salt of pyrrolidone carboxylic acid 加巴国际股份有限公司 2020-09-01 CN disclosed
EP-3221008-B1 MOUTHRINSE FORMULATIONS GABA INT HOLDING GMBH (CH) 2020-05-13 EP disclosed
EP-3215229-B1 MOUTHRINSE FORMULATIONS GABA INT HOLDING GMBH (CH) 2020-04-01 EP disclosed
US-10391047-B2 Mouthrinse formulations comprising fluoride and a metal salt of pyrrolidone carboxylic acid COLGATE-PALMOLIVE COMPANY (US) 2019-08-27 US disclosed
US-20180021228-A1 Mouthrinse Formulations GABA INTERNATIONAL HOLDING GMBH (CH) 2018-01-25 US disclosed
US-20180015014-A1 Mouthrinse Formulations GABA INTERNATIONAL HOLDING GMBH (CH) 2018-01-18 US disclosed
US-20170348216-A1 Mouthrinse Formulations Comprising Fluoride and a Metal Salt of Pyrrolidone Carboxylic Acid GABA INTERNATIONAL HOLDING GMBH (CH) 2017-12-07 US disclosed
EP-3223781-A1 MOUTHRINSE FORMULATIONS COMPRISING FLUORIDE AND A METAL SALT OF PYRROLIDONE CARBOXYLIC ACID GABA International Holding GmbH (CH) 2017-10-04 EP disclosed
EP-3221008-A1 MOUTHRINSE FORMULATIONS GABA International Holding GmbH (CH) 2017-09-27 EP disclosed
EP-3215229-A1 MOUTHRINSE FORMULATIONS GABA International Holding GmbH (CH) 2017-09-13 EP disclosed
US-20170071834-A1 STABILIZED OXYRESVERATROL COMPOSITIONS PANGAEA LABORATORIES LIMITED (GB) 2017-03-16 US disclosed
WO-2016100802-A1 MOUTHRINSE FORMULATIONS COLGATE-PALMOLIVE COMPANY (US) 2016-06-23 WO disclosed
WO-2016100628-A1 MOUTHRINSE FORMULATIONS COLGATE-PALMOLIVE COMPANY (US) 2016-06-23 WO disclosed
WO-2016096028-A1 MOUTHRINSE FORMULATIONS COMPRISING FLUORIDE AND A METAL SALT OF PYRROLIDONE CARBOXYLIC ACID GABA INTERNATIONAL HOLDING AG (CH) 2016-06-23 WO disclosed
US-20130196957-A1 ROLL-ON WITH HIGH SALICYLIC ACID CONTENT L'OREAL (FR) 2013-08-01 US disclosed
US-20130171079-A1 COMPOSITION TO STABILISE KOJIC ACID PANGAEA LABORATORIES LTD. (GB) 2013-07-04 US disclosed
US-8337869-B2 Analgesic cream GROSS ROBERT L (US) 2012-12-25 US disclosed
WO-2012080994-A2 N-ACYLATED AMINO ACID ESTER AS SOOTHING AGENT L'OREAL (FR) 2012-06-21 WO disclosed
WO-2011101239-A2 COSMETIC OR DERMATOLOGICAL USES OF A POWDER COMPRISING A FILLER, AN ESSENTIAL OIL AND A HYDROXYLATED ESTER OF POLYOL AND OF C4 TO C16 CARBOXYLIC ACID(S) L'OREAL (FR) 2011-08-25 WO disclosed
US-20100256100-A1 ROLL-ON WITH HIGH SALICYLIC ACID CONTENT L'OREAL (FR) 2010-10-07 US disclosed
WO-2009021119-A1 ANALGESIC CREAM NABOB RX (US) 2009-02-12 WO disclosed
US-20090041857-A1 Analgesic Cream NABOB RX (US) 2009-02-12 US disclosed
US-5037803-A An aqueous solution containing a protein which fixes active substance to the skin BONDON, JACQUES 1991-08-06 US disclosed
US-5037803-A An aqueous solution containing a protein which fixes active substance to the skin BONDON, JACQUES 1991-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256100-A1 ROLL-ON WITH HIGH SALICYLIC ACID CONTENT SUCLG1, CUTA, SYVN1 LMNA 3282/4885KMT2A 4127/4885CYP1A2 2544/4885
US-20240216242-A1 COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS KRT18, CUTA, DSG1 LMNA 1823/4885KMT2A 686/4885CYP1A2 4563/4885
US-20250302727-A1 COSMETIC USE OF A COMBINATION OF IMMORTELLE EXTRACTS TO REDUCE THE VISIBILITY OF SKIN PORES CUTA, IMMT, SYMPK LMNA 446/4885KMT2A 4033/4885CYP1A2 2718/4885
US-10391047-B2 Mouthrinse formulations comprising fluoride and a metal salt of pyrrolidone carboxylic acid PHPT1, NHERF1, PHF6 LMNA 4744/4885KMT2A 1872/4885CYP1A2 1777/4885
US-20170348216-A1 Mouthrinse Formulations Comprising Fluoride and a Metal Salt of Pyrrolidone Carboxylic Acid PHPT1, P4HA1, NHERF1 LMNA 4733/4885KMT2A 2197/4885CYP1A2 2308/4885
US-20130196957-A1 ROLL-ON WITH HIGH SALICYLIC ACID CONTENT SUCLG1, CUTA, SYVN1 LMNA 3282/4885KMT2A 4127/4885CYP1A2 2544/4885
US-20240269053-A1 COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS KRT18, CUTA, S100A4 LMNA 983/4885KMT2A 740/4885CYP1A2 4840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.